Prot #STML-701-0114: A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme

Project: Research project

Project Details

StatusFinished
Effective start/end date6/26/146/26/19

Funding

  • INC Research, LLC (Prot #STML-701-0114)
  • Stemline Therapeutics, Inc. (Prot #STML-701-0114)